COMBINED USE OF OLMESARTAN MEDOXOMIL AND AZELNIDIPINE OR AMLODIPINE FOR THE TREATMENT OF ARTERIOSCLEROSIS AND HYPERTENSION

摘要

A medicament comprising the following composition: (A) an angiotensin II
receptor
antagonist selected from the group of a compound having a general formula (I),

pharmacologically acceptable esters thereof and pharmacologically acceptable
salts
thereof (for example, olmesartan medoxomil and the like);
(see formula I)



and (B) a calcium channel blocker selected from the group consisting of
1,4-dihydropyridine derivatives and pharmacologically acceptable salts thereof
as active
ingredients (for example, azelnidipine and the like) for the prophylaxis
and/or treatment
of arteriosclerosis, hypertension, heart diseases, renal diseases or
cerebrovascular
diseases.